Clinical Trial Update: Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

This is an update on a completed Phase 1/2 trial evaluating chemotherapy, SU5416, radiation therapy, and surgery in soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• SU5416 (semaxanib)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Sarcoma | Phase 1, Phase 2 | Status: COMPLETED